Viewing Study NCT00250432


Ignite Creation Date: 2025-12-24 @ 9:44 PM
Ignite Modification Date: 2026-03-28 @ 12:14 PM
Study NCT ID: NCT00250432
Status: COMPLETED
Last Update Posted: 2017-03-24
First Post: 2005-11-04
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 0991-801
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators